MRI and Targeted Biopsy Essential Tools for an Accurate Diagnosis and Treatment Decision Making in Prostate Cancer
Prostate cancer (PCa) is one of the most frequent causes of cancer death worldwide. Historically, diagnosis was based on physical examination, transrectal (TRUS) images, and TRUS biopsy resulting in overdiagnosis and overtreatment. Recently magnetic resonance imaging (MRI) has been identified as an...
Main Authors: | Suraj Samtani, Mauricio Burotto, Juan Carlos Roman, Daniela Cortes-Herrera, Annerleim Walton-Diaz |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4418/11/9/1551 |
Similar Items
-
Multiparametric MRI and targeted biopsies in the management of prostate cancer patients on active surveillance
by: Kiri eSandler, et al.
Published: (2015-01-01) -
The role of mpMRI in qualification of patients with ISUP 1 prostate cancer on biopsy to radical prostatectomy
by: Łukasz Nyk, et al.
Published: (2021-05-01) -
MRI and Active Surveillance for Prostate Cancer
by: Angelo Porreca, et al.
Published: (2020-08-01) -
Detection rate for significant cancer at confirmatory biopsy in men enrolled in Active Surveillance protocol: 20 cores vs 30 cores vs MRI/TRUS fusion prostate biopsy
by: Pietro Pepe, et al.
Published: (2016-12-01) -
MRI/US fusion prostate biopsy in men on active surveillance: Our experience
by: Vito Lacetera, et al.
Published: (2021-03-01)